Search research articles
Contact Us
Filters
Showing results (271-280 of 289) with videos related to
Page
of 29
Sort By:
The Medical Journal of Australia
|
February 7, 1981
Renal transplantation. 12-Year experience
P E Hurst, J G Brockis, R L Dawkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
P Mitchell, N Thatcher, M A Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients
W P Steward, J von Pawel, U Gatzemeier, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2013
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
S Ramalingam, J Crawford, A Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
P Wheatley-Price, F Blackhall, S-M Lee, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
May 16, 1970
Renal transplantation at Groote Schuur Hospital: a report of 13 cases
C J Uys, J R Ackermann, G N Thatcher, et al.
British Journal of Cancer
|
August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer
H Anderson, P Hopwood, R J Stephens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
J D Cox, T Le Chevalier, R Arriagada, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 289) with videos related to
Sort By:
Page
of 29
The Medical Journal of Australia
|
February 7, 1981
Renal transplantation. 12-Year experience
P E Hurst, J G Brockis, R L Dawkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
P Mitchell, N Thatcher, M A Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2003
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma
B W Hancock, K Wheatley, S Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients
W P Steward, J von Pawel, U Gatzemeier, et al.
British Journal of Cancer
|
July 17, 1999
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
N Thatcher, E S De Campos, D R Bell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2013
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
S Ramalingam, J Crawford, A Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2010
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
P Wheatley-Price, F Blackhall, S-M Lee, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
May 16, 1970
Renal transplantation at Groote Schuur Hospital: a report of 13 cases
C J Uys, J R Ackermann, G N Thatcher, et al.
British Journal of Cancer
|
August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer
H Anderson, P Hopwood, R J Stephens, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
J D Cox, T Le Chevalier, R Arriagada, et al.
Page
of 29